Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | SRC | P12931 | 2/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 1/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14871996 | 1.00 | CYP2D6 (0.52) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL2478440 | 1.00 | CYP2D6 (0.52) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL9450258 | 0.85 | OPRK1 (0.52) | CYP2D6OPRK1LMNAHDAC4HDAC1 | |
| SCHEMBL22468482 | 0.84 | SRD5A2 (0.47) | — | |
| SCHEMBL15359365 | 0.84 | OPRK1 (0.47) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL10402082 | 0.84 | OPRK1 (0.44) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL8645113 | 0.84 | OPRK1 (0.44) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL12174989 | 0.84 | OPRK1 (0.47) | CYP2D6SRCOPRK1LMNAMAPK1 | |
| SCHEMBL11503746 | 0.84 | SRC (0.47) | CYP2D6SRCOPRK1KMT2ANAALAD2 | |
| SCHEMBL10402081 | 0.84 | OPRK1 (0.44) | CYP2D6SRCOPRK1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110177783-A | Hormone receptor modulators for the treatment of metabolic conditions and disorders | 阿德利克斯股份有限公司 | 2019-08-27 | — | — | CN | claimed |
| US-12384810-B2 | Organometallic compound and light-emitting device including organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| WO-2023020789-A1 | METHODS FOR PREPARING OXAZABOROLIDINES | PATHWAY INTERMEDIATES LIMITED (GB) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023020789-A1 | METHODS FOR PREPARING OXAZABOROLIDINES | PATHWAY INTERMEDIATES LIMITED (GB) | 2023-02-23 | — | — | WO | disclosed |
| US-20220246868-A1 | ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-08-04 | — | — | US | disclosed |
| CN-110177783-A | Hormone receptor modulators for the treatment of metabolic conditions and disorders | 阿德利克斯股份有限公司 | 2019-08-27 | — | — | CN | disclosed |
| CN-102976970-B | Preparation method of isocyano compound | UNIV NANJING SCIENCE & TECH | 2014-12-17 | — | — | CN | disclosed |
| EP-2435433-B1 | (DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES AS FSH RECEPTOR AGONISTS FOR THE TREATMENT OF FERTILITY DISORDERS | MERCK SHARP & DOHME (NL) | 2013-08-28 | — | — | EP | disclosed |
| US-8071587-B2 | (Dihydro)imidazoiso[5,1-A]quinolines | N. V. ORGANON (NL) | 2011-12-06 | — | — | US | disclosed |
| US-8071587-B2 | (Dihydro)imidazoiso[5,1-A]quinolines | N. V. ORGANON (NL) | 2011-12-06 | — | — | US | disclosed |
| US-20100324021-A1 | (DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES | N.V. ORGANON (NL) | 2010-12-23 | — | — | US | disclosed |
| WO-2010136438-A1 | (DIHYDRO) IMIDAZOISO (5, 1-A) QUINOLINES AS FSH RECEPTOR AGONISTS FOR THE TREATMENT OF FERTILITY DISORDERS | N.V. ORGANON (NL) | 2010-12-02 | — | — | WO | disclosed |
| WO-2010136438-A1 | (DIHYDRO) IMIDAZOISO (5, 1-A) QUINOLINES AS FSH RECEPTOR AGONISTS FOR THE TREATMENT OF FERTILITY DISORDERS | N.V. ORGANON (NL) | 2010-12-02 | — | — | WO | disclosed |
| EP-1924551-A2 | ORGANIC COMPOUNDS | Novartis Pharma AG (CH) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007025709-A2 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2007-03-08 | — | — | WO | disclosed |
| EP-0775110-A1 | ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004242-A1 | ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
| US-5232978-A | 1-(2-arylethyl)-pyrrolidines | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-08-03 | — | — | US | disclosed |
| US-3996216-A | 3-Heterothio derivatives of (formylamino)acetylamino-7-alpha-methoxy cephalosporins | E. R. SQUIBB & SONS, INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3949079-A | PLEUROMUTILIN; BACTERICIDES IN ANIMAL FEEDS | BIOCHEMIE GES.M.B.H. (OE) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324021-A1 | (DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES | NQO2, IPO5, SCN5A | CYP2D6 306/4885SRC 4146/4885OPRK1 1089/4885 |
| US-20220246868-A1 | ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND | LEF1, CRY1, DDT | CYP2D6 256/4885SRC 3443/4885OPRK1 3229/4885 |
| US-12384810-B2 | Organometallic compound and light-emitting device including organometallic compound | LEF1, CRY1, DDT | CYP2D6 256/4885SRC 3443/4885OPRK1 3229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.